Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
109955301000001114 | Daunorubicin 44mg / Cytarabine 100mg powder for concentrate for solution for infusion vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110035601000001113 | Daunorubicin 44mg / Cytarabine 100mg powder for solution for infusion vials | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Is a | True | Daunorubicin 44mg / Cytarabine 100mg powder for concentrate for solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Daunorubicin 44mg / Cytarabine 100mg powder for concentrate for solution for infusion vials 1 vial | Has VMP | True | Daunorubicin 44mg / Cytarabine 100mg powder for concentrate for solution for infusion vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets